Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy; and.
Retina. 2023 Sep 1;43(9):1563-1572. doi: 10.1097/IAE.0000000000003845.
To assess relationships between demographics, clinical characteristics, and optical coherence tomography characteristics with persistence of metamorphopsia after resolution of subretinal fluid in eyes with chronic central serous chorioretinopathy.
One-hundred participants with "resolved" (absence of subretinal fluid) chronic central serous chorioretinopathy were retrospectively analyzed. Patients underwent a complete ophthalmologic evaluation, including assessment of the presence of metamorphopsia. At the study visit, optical coherence tomography scans were reviewed for qualitative and quantitative features.
Sixty-six of 100 patients (66.0%) complained of metamorphopsia. Both the foveal and parafoveal ganglion cell complex thicknesses were thinner in central serous chorioretinopathy eyes with metamorphopsia (35.1 ± 10.6 µ m and 82.0 ± 18.1 µ m vs. 40.7 ± 11.8 µ m and 93.1 ± 13.5 µ m, P = 0.030 and P < 0.0001). In the foveal region, the outer plexiform layer and outer nuclear layer thicknesses were thinner in patients with metamorphopsia (24.6 ± 8.5 µ m and 63.1 ± 20.9 µ m vs. 29.1 ± 8.7 and 76.2 ± 18.2 µ m, P = 0.016 and P = 0.005). The ellipsoid zone band was more frequently discontinued in eyes with metamorphopsia (56.1% vs. 35.3%, P = 0.039). Multivariate stepwise linear regression analysis demonstrated that the strongest associations with the presence of metamorphopsia were with parafoveal ganglion cell complex thickness ( P = 0.004), foveal outer nuclear layer thickness ( P = 0.010), and number of previous recurrences of subretinal fluid accumulation ( P = 0.017). The time interval from the last subretinal fluid resolution was not associated with the presence of metamorphopsia.
In "resolved" central serous chorioretinopathy, clinical aspects (i.e., number of previous recurrences) and structural changes (i.e., ganglion cell complex and outer nuclear layer thinning) are associated with metamorphopsia after subretinal fluid resolution.
评估人口统计学、临床特征和光相干断层扫描特征与慢性中心性浆液性脉络膜视网膜病变患者视网膜下液消退后仍存在的光幻视之间的关系。
回顾性分析 100 例“已消退”(无视网膜下液)慢性中心性浆液性脉络膜视网膜病变患者的资料。患者接受了全面的眼科评估,包括对光幻视的评估。在研究访视时,对光学相干断层扫描扫描进行定性和定量特征评估。
100 例患者中有 66 例(66.0%)诉有光幻视。有光幻视的中心性浆液性脉络膜视网膜病变眼的中心凹和旁中心凹神经节细胞复合体厚度均变薄(35.1±10.6µm 和 82.0±18.1µm 与 40.7±11.8µm 和 93.1±13.5µm,P=0.030 和 P<0.0001)。在中心凹区域,光幻视患者的外丛状层和外核层厚度变薄(24.6±8.5µm 和 63.1±20.9µm 与 29.1±8.7µm 和 76.2±18.2µm,P=0.016 和 P=0.005)。光幻视患者的椭圆体带更常中断(56.1%比 35.3%,P=0.039)。多元逐步线性回归分析表明,与光幻视存在最强关联的是旁中心凹神经节细胞复合体厚度(P=0.004)、中心凹外核层厚度(P=0.010)和视网膜下液积聚复发次数(P=0.017)。从最后一次视网膜下液消退到现在的时间间隔与光幻视的存在无关。
在“已消退”的中心性浆液性脉络膜视网膜病变中,临床方面(即,复发次数)和结构变化(即,神经节细胞复合体和外核层变薄)与视网膜下液消退后光幻视的出现有关。